• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺D3受体基因多态性与锰超氧化物歧化酶基因多态性在迟发性运动障碍易感性中的相互作用。

Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.

作者信息

Zhang Zhi Jun, Zhang Xiao Bin, Hou Gang, Yao Hui, Reynolds Gavin P

机构信息

Department of Psychiatry, Nanjing Brain Hospital and Nanjing Medical University, Nanjing, People's Republic of China.

出版信息

Psychiatr Genet. 2003 Sep;13(3):187-92. doi: 10.1097/00041444-200309000-00010.

DOI:10.1097/00041444-200309000-00010
PMID:12960753
Abstract

OBJECTIVES

To investigate the influence of a functional polymorphism of the dopamine D3 receptor (DRD3), and assess its interaction with a Mn superoxide dismutase (MnSOD) polymorphism, in contributing to tardive dyskinesia in a chronic inpatient population with schizophrenia.

METHODS

Chinese Han patients with schizophrenia were assessed for abnormal involuntary movements, and subgroups of 42 patients with persistent tardive dyskinesia and 59 consistently without dyskinesias were assessed for the DRD3 ser9gly and the MnSOD ala-9val polymorphisms.

RESULTS

A higher, but not significant, frequency of DRD3 ser/gly heterozygotes was observed in the tardive dyskinesia group (0.52 versus 0.33, chi2=5, degrees of freedom=2, P=0.08). However, assessment of the combined influence of the two polymorphisms demonstrated a significant effect (chi2=8.09, degrees of freedom=3, P=0.04), whereby the combination of the MnSOD -9val and DRD3 9ser alleles was associated with tardive dyskinesia.

CONCLUSIONS

These results indicate a possible synergistic effect of genetic factors influencing mitochondrial free radical scavenging and dopamine receptor function on the susceptibility to tardive dyskinesia.

摘要

目的

研究多巴胺D3受体(DRD3)功能多态性的影响,并评估其与锰超氧化物歧化酶(MnSOD)多态性的相互作用,以探讨其在慢性精神分裂症住院患者迟发性运动障碍中的作用。

方法

对中国汉族精神分裂症患者进行异常不自主运动评估,对42例持续性迟发性运动障碍患者和59例无运动障碍患者的亚组进行DRD3 ser9gly和MnSOD ala-9val多态性评估。

结果

迟发性运动障碍组中DRD3 ser/gly杂合子的频率较高,但无统计学意义(0.52对0.33,χ2=5,自由度=2,P=0.08)。然而,对两种多态性联合影响的评估显示出显著效应(χ2=8.09,自由度=3,P=0.04),其中MnSOD -9val和DRD3 9ser等位基因的组合与迟发性运动障碍相关。

结论

这些结果表明,影响线粒体自由基清除和多巴胺受体功能的遗传因素可能对迟发性运动障碍的易感性产生协同作用。

相似文献

1
Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.多巴胺D3受体基因多态性与锰超氧化物歧化酶基因多态性在迟发性运动障碍易感性中的相互作用。
Psychiatr Genet. 2003 Sep;13(3):187-92. doi: 10.1097/00041444-200309000-00010.
2
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].抗精神病药物所致迟发性运动障碍的药物遗传学评估:5-羟色胺2C受体基因以及多巴胺D3变异等位基因(甘氨酸)与锰超氧化物歧化酶野生等位基因(缬氨酸)组合的作用
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102.
3
Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.中国精神分裂症患者中多巴胺D3受体基因ser9gly和脑源性神经营养因子基因val66met多态性与抗精神病药物所致持续性迟发性运动障碍及临床表型的关联分析
Neuromolecular Med. 2004;5(3):243-51. doi: 10.1385/NMM:5:3:243.
4
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.中国精神分裂症患者多巴胺D3受体基因Ser9Gly多态性与迟发性运动障碍的关联
Neuropsychobiology. 2001;44(2):95-8. doi: 10.1159/000054924.
5
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.迟发性运动障碍的药物遗传学:780例患者的联合分析支持与多巴胺D3受体基因Ser9Gly多态性相关
Neuropsychopharmacology. 2002 Jul;27(1):105-19. doi: 10.1016/S0893-133X(02)00293-2.
6
[Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].[波兰中部患有迟发性运动障碍的精神分裂症患者的锰超氧化物歧化酶基因(MnSOD)多态性]
Psychiatr Pol. 2006 Sep-Oct;40(5):937-48.
7
Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.锰超氧化物歧化酶Ala-9Val多态性与科萨族人群精神分裂症及异常不自主运动发生之间的关联
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):664-72. doi: 10.1016/j.pnpbp.2006.12.019. Epub 2007 Jan 12.
8
Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.锰超氧化物歧化酶基因 Ala-9Val 多态性与精神分裂症患者临床表型和迟发性运动障碍的关联。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):692-6. doi: 10.1016/j.pnpbp.2010.03.026. Epub 2010 Mar 25.
9
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.精神分裂症患者中,奎宁氧化还原酶基因(NQO1:Pro187Ser)与锰超氧化物歧化酶基因(MnSOD:Ala-9Val)多态性对迟发性运动障碍的叠加效应。
Psychiatry Res. 2008 Dec 15;161(3):336-8. doi: 10.1016/j.psychres.2006.10.005. Epub 2008 Oct 31.
10
Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.慢性精神分裂症患者中血清素2C受体基因与迟发性运动障碍的关联:5-HT2Cser和DRD3gly等位基因对易感性的累加作用。
Psychopharmacology (Berl). 2000 Nov;152(4):408-13. doi: 10.1007/s002130000521.

引用本文的文献

1
for Tardive Dyskinesia and Plasma Activity: Association with Ala-9Val Variant: A Randomized, Double-blind Trial.用于迟发性运动障碍和血浆活性:与 Ala-9Val 变体的关联:一项随机、双盲试验。
Curr Neuropharmacol. 2024;22(14):2443-2452. doi: 10.2174/1570159X22666240530095721.
2
Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.迟发性运动障碍的发展、超氧化物歧化酶水平与相关基因多态性
Oxid Med Cell Longev. 2022 Oct 28;2022:5748924. doi: 10.1155/2022/5748924. eCollection 2022.
3
Medication-Induced Tardive Dyskinesia: A Review and Update.
药物性迟发性运动障碍:综述与更新
Ochsner J. 2017 Summer;17(2):162-174.
4
Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.锰超氧化物歧化酶活性、基因Ala-9Val多态性与精神分裂症风险的Meta分析
Medicine (Baltimore). 2015 Sep;94(36):e1507. doi: 10.1097/MD.0000000000001507.
5
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.接受非典型抗精神病药物治疗患者的迟发性运动障碍:病例系列及病因与治疗考量简述
Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.
6
An update on tardive dyskinesia: from phenomenology to treatment.迟发性运动障碍的最新进展:从现象学到治疗
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3. doi: 10.7916/D88P5Z71. Print 2013.
7
Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study.长期住院精神科患者的抗精神病药引起的运动障碍与 7 个候选基因中的 45 个标签 SNP:一项前瞻性研究。
PLoS One. 2012;7(12):e50970. doi: 10.1371/journal.pone.0050970. Epub 2012 Dec 4.
8
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.迟发性运动障碍药物基因组检测应用中的伦理与政策考量:以多巴胺D3受体为例
Curr Pharmacogenomics Person Med. 2011 Jun 1;9(2):94-101. doi: 10.2174/187569211795508448.
9
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.药物遗传学与抗精神病药:疗效和副作用预测。
Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37. doi: 10.1517/17425255.2011.532787.
10
Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.阿尔茨海默病中的突触功能障碍与氧化应激:新出现的机制
J Cell Mol Med. 2006 Jul-Sep;10(3):796-805. doi: 10.1111/j.1582-4934.2006.tb00439.x.